Chronic Myeloid Leukaemia: Changing the treatment paradigm [ 2018 - 2021 ]

Research Grant

[Cite as]

Researchers: Prof Timothy Hughes (Principal investigator) ,  A/Pr Susan Branford Dr David Ross Prof Deborah White

Brief description Most patients with chronic myeloid leukaemia achieve excellent responses to therapy but need therapy for life. We have pioneered the concept that some patients can cease their therapy and not relapse (treatment free remission –TFR). By studying the immune system and the leukaemic stem cells we will determine why TFR is possible for some, but not all patients. This holds the key to improving the rate of TFR, thus moving the CML goal from disease control to cure.

Funding Amount $AUD 1,179,056.96

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]